Our Focus

Key:

Migraine & Pain

Neurology & neuropsychiatry

Respiratory

Biosimilars

Others TA

Notes:

Pipeline is current as of Aug 7, 2017.* Approved in the U.S under the trade name: CINQAIR® **In partnership with Regeneron *** In partnership with Celltrion **** Submitted by Takeda ***** In partnership with Eagle Pharmaceuticals

Download

Download Pdf
To download a file, please right click on the file name and choose "save target as"